WuXi AppTec provides a seamless, high-quality, single-source approach for the development and testing of biotherapeutics. This single-source strategy can reduce the time to clinic and can significantly decrease the cost of our customers' drug development efforts. For cell therapies, WuXi AppTec also offers cGMP manufacturing. The requirements of moving a new drug through the various phases of product development involve intensive oversight of a vast number of different programs. Having a single-source provider for these activities – with one project manager as a single point of contact – allows for seamless transition from program to program and provides inherent economies of scale.